The panel includes: Marj Charlier, Vice President, Investor Relations, RealNetworks, Inc. and Anne Bugge, Vice President, Corporate Affairs, Sonosite, Inc.

Marj joined Real Networks, a leading creator of digital media services and software, in December as Vice President of Investor Relations. Previously, she served as Director of Investor Relations at Expedia, Inc., IAC/Interactive Corp., Cyprus Amax Minerals Co. and Amax Gold Inc. In addition, she created and developed clientele for the investor relations practice of Johnston Wells Public Relations Company in Denver. Marj also served as Director of Corporate Social Responsibility for two years at Expedia, Inc., creating the first corporate philanthropy and cause-related marketing programs at the company, including the conception and negotiation of the World Heritage Alliance with the United Nations Foundation. For a dozen years prior to her investor relations career, Marj was a reporter with the Wall Street Journal. She has a BA in Journalism and International Studies from Iowa State University, where she was inducted into Phi Beta Kappa; a masters degree in Journalism and Environmental Studies from the University of Wisconsin Madison; and an MBA from Regis University in Denver. In 2006, Marj received the Distinguished Service Award from the University of Wisconsin Journalism School. She serves on the non-profit boards at the University of Wisconsin and the Global Heritage Fund.

Anne joined SonoSite, the world leader in hand-carried ultrasound, in February 2005 and is responsible for developing and managing SonoSite's corporate and investor communications worldwide. Prior to SonoSite, she worked with the EVC Group, an investor and corporate communications firm specializing in advising small cap companies. Anne also served as Vice President, Corporate and Investor Relations for ATL Ultrasound, Inc. from 1987 until its acquisition by Philips Medical Systems in 1998. She received a bachelor of arts degree in journalism from Michigan State University, continued academic studies at the University of Oslo and completed the Stanford University Executive Program.

The panel will be moderated by Dan Eramian, Executive Vice President, Cell Therapeutics, Inc. Dan, who joined CTI as Executive Vice President, Corporate Communications in March 2006, is a member of the Company's senior management team and is responsible for developing and implementing the internal and external communications strategy. Dan brings nearly 13 years of experience in the biotechnology industry to the position. Most recently he was Vice President of Communications at BIO, a Washington, DC based industry organization representing more than 1,200 biotechnology companies, academic institutions, state biotechnology centers, and related organizations. Prior to BIO, Dan was Assistant Administrator of Communications at the Small Business Administration and Director of Public Affairs at the Department of Justice and Chief Spokesman for the Attorney General. Previously, he served as Chief of Staff to the Senate Leader in the Massachusetts Legislature, and was also Executive Editor of Suburban World Newspapers in the Boston area. Dan holds a B.A. in English Literature from UMass/Amherst and an M.P.A. from Suffolk University.